Copyright Reports & Markets. All rights reserved.

Global Synovial Sarcoma Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Synovial Sarcoma Treatment Market Overview

      • 1.1 Product Overview and Scope of Synovial Sarcoma Treatment
      • 1.2 Synovial Sarcoma Treatment Segment by Type
        • 1.2.1 Global Synovial Sarcoma Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 ACXT-3102
        • 1.2.3 AL-3818
        • 1.2.4 Axitinib
        • 1.2.5 CMB-305
        • 1.2.6 CUE-102
        • 1.2.7 Others
      • 1.3 Synovial Sarcoma Treatment Segment by Application
        • 1.3.1 Synovial Sarcoma Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Synovial Sarcoma Treatment Market by Region
        • 1.3.1 Global Synovial Sarcoma Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Synovial Sarcoma Treatment Market Size
        • 1.4.1 Global Synovial Sarcoma Treatment Revenue (2014-2025)
        • 1.4.2 Global Synovial Sarcoma Treatment Production (2014-2025)

      2 Global Synovial Sarcoma Treatment Market Competition by Manufacturers

      • 2.1 Global Synovial Sarcoma Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Synovial Sarcoma Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Synovial Sarcoma Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Synovial Sarcoma Treatment Production Sites, Area Served, Product Types
      • 2.5 Synovial Sarcoma Treatment Market Competitive Situation and Trends
        • 2.5.1 Synovial Sarcoma Treatment Market Concentration Rate
        • 2.5.2 Synovial Sarcoma Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Synovial Sarcoma Treatment Production Market Share by Regions

      • 3.1 Global Synovial Sarcoma Treatment Production Market Share by Regions
      • 3.2 Global Synovial Sarcoma Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Synovial Sarcoma Treatment Production
        • 3.4.1 North America Synovial Sarcoma Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Synovial Sarcoma Treatment Production
        • 3.5.1 Europe Synovial Sarcoma Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Synovial Sarcoma Treatment Production (2014-2019)
        • 3.6.1 China Synovial Sarcoma Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Synovial Sarcoma Treatment Production (2014-2019)
        • 3.7.1 Japan Synovial Sarcoma Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Synovial Sarcoma Treatment Consumption by Regions

      • 4.1 Global Synovial Sarcoma Treatment Consumption by Regions
      • 4.2 North America Synovial Sarcoma Treatment Consumption (2014-2019)
      • 4.3 Europe Synovial Sarcoma Treatment Consumption (2014-2019)
      • 4.4 China Synovial Sarcoma Treatment Consumption (2014-2019)
      • 4.5 Japan Synovial Sarcoma Treatment Consumption (2014-2019)

      5 Global Synovial Sarcoma Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Synovial Sarcoma Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Synovial Sarcoma Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Synovial Sarcoma Treatment Price by Type (2014-2019)
      • 5.4 Global Synovial Sarcoma Treatment Production Growth by Type (2014-2019)

      6 Global Synovial Sarcoma Treatment Market Analysis by Applications

      • 6.1 Global Synovial Sarcoma Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Synovial Sarcoma Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Synovial Sarcoma Treatment Business

      • 7.1 Adaptimmune Therapeutics Plc
        • 7.1.1 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.1.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.1.3 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Advenchen Laboratories LLC
        • 7.2.1 Advenchen Laboratories LLC Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.2.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.2.3 Advenchen Laboratories LLC Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 EpiZyme Inc
        • 7.3.1 EpiZyme Inc Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.3.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.3.3 EpiZyme Inc Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Immune Design Corp
        • 7.4.1 Immune Design Corp Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.4.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.4.3 Immune Design Corp Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Immunocore Ltd
        • 7.5.1 Immunocore Ltd Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.5.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.5.3 Immunocore Ltd Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Johnson & Johnson
        • 7.6.1 Johnson & Johnson Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.6.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.6.3 Johnson & Johnson Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Karyopharm Therapeutics Inc
        • 7.7.1 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.7.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.7.3 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Merck & Co Inc
        • 7.8.1 Merck & Co Inc Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.8.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.8.3 Merck & Co Inc Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Millennium Pharmaceuticals Inc
        • 7.9.1 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.9.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.9.3 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis AG
        • 7.10.1 Novartis AG Synovial Sarcoma Treatment Production Sites and Area Served
        • 7.10.2 Synovial Sarcoma Treatment Product Introduction, Application and Specification
        • 7.10.3 Novartis AG Synovial Sarcoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Pfizer Inc
      • 7.12 Takara Bio Inc

      8 Synovial Sarcoma Treatment Manufacturing Cost Analysis

      • 8.1 Synovial Sarcoma Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Synovial Sarcoma Treatment
      • 8.4 Synovial Sarcoma Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Synovial Sarcoma Treatment Distributors List
      • 9.3 Synovial Sarcoma Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Synovial Sarcoma Treatment Market Forecast

      • 11.1 Global Synovial Sarcoma Treatment Production, Revenue Forecast
        • 11.1.1 Global Synovial Sarcoma Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Synovial Sarcoma Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Synovial Sarcoma Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Synovial Sarcoma Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Synovial Sarcoma Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Synovial Sarcoma Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Synovial Sarcoma Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Synovial Sarcoma Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Synovial Sarcoma Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Synovial Sarcoma Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Synovial Sarcoma Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Synovial Sarcoma Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Synovial Sarcoma Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Synovial Sarcoma Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Synovial Sarcoma Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Synovial Sarcoma Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Synovial Sarcoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Synovial Sarcoma Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Adaptimmune Therapeutics Plc
        Advenchen Laboratories LLC
        EpiZyme Inc
        Immune Design Corp
        Immunocore Ltd
        Johnson & Johnson
        Karyopharm Therapeutics Inc
        Merck & Co Inc
        Millennium Pharmaceuticals Inc
        Novartis AG
        Pfizer Inc
        Takara Bio Inc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        ACXT-3102
        AL-3818
        Axitinib
        CMB-305
        CUE-102
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now